Dr. Thomas S. Crawford, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3 High St., Milbridge, ME 04658 Phone: 207-546-2357 Fax: 207-546-7484 |
Thomas S Crawford Optometrist Medicare: Not Enrolled in Medicare Practice Location: # 3 High St, Milbridge, ME 04658 Phone: 207-546-2357 Fax: 207-546-7484 |
News Archive
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
Medical device company Vertos Medical Inc. has announced the unveiling of 12-week clinical data from its prospective, 75-patient MiDAS I (mild Decompression Alternative to open Surgery) study that further validate the safety and efficacy of mild for the treatment of lumbar spinal stenosis (LSS). Consistent with the positive six-week study results released in March and May, the new MiDAS I data demonstrate that mild patients continued to experience statistically significant improvement in pain, physical function and mobility 12 weeks following treatment.
For HIV patients being treated with anti-AIDS medications, resistance to drug therapy regimens is commonplace. Often, patients develop resistance to first-line drug therapies, such as Tenofovir, and are forced to adopt more potent medications.
Researchers in Aberdeen have launched a study to see whether a new blood test can better predict the outcome for patients facing heart surgery.
› Verified 3 days ago